{"product_id":"semaglutide-4mg-auto-injector-pen","title":"Semaglutide 4mg Auto-Injector Pen","description":"\u003cdiv class=\"woocommerce-tabs wc-tabs-wrapper\"\u003e\n\u003cdiv aria-labelledby=\"tab-title-description\" role=\"tabpanel\" id=\"tab-description\" class=\"woocommerce-Tabs-panel woocommerce-Tabs-panel--description panel entry-content wc-tab\"\u003e\n\u003cp data-end=\"717\" data-start=\"387\"\u003e\u003cstrong data-end=\"198\" data-start=\"182\"\u003ePlease note:\u003c\/strong\u003e This item is shipped directly from the manufacturer. Delivery may take slightly longer than usual, with an estimated turnaround time of 5 to 7 working days.\u003c\/p\u003e\n\u003cp data-end=\"717\" data-start=\"387\"\u003eNovo-Lela Semaglutide 4mg Auto-Injector Pen contains Semaglutide, a GLP-1 receptor agonist approved for the treatment of type 2 diabetes. Semaglutide replicates the action of human glucagon-like peptide-1, enhancing glucose-dependent insulin secretion and suppressing glucagon release to regulate blood sugar levels effectively.\u003c\/p\u003e\n\u003cp data-end=\"1159\" data-start=\"719\"\u003eAs a next-generation incretin therapy, Semaglutide has shown significant efficacy in reducing HbA1c levels and promoting weight loss. Clinical studies consistently demonstrate that Semaglutide provides superior glycaemic control compared to placebo and many other GLP-1 receptor agonists. Its additional effects on delaying gastric emptying further improve postprandial glucose control and contribute to reduced appetite and caloric intake.\u003c\/p\u003e\n\u003cp data-end=\"1310\" data-start=\"1161\"\u003eThe Auto-Injector Pen format offers a convenient, prefilled option for once-weekly subcutaneous administration, making treatment simple and discreet.\u003c\/p\u003e\n\u003chr data-end=\"1315\" data-start=\"1312\"\u003e\n\u003ch4 data-end=\"1350\" data-start=\"1317\"\u003e\u003cstrong data-end=\"1350\" data-start=\"1322\"\u003eBenefits of Semaglutide:\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cul data-end=\"1782\" data-start=\"1352\"\u003e\n\u003cli data-end=\"1515\" data-start=\"1352\"\u003e\n\u003cp data-end=\"1515\" data-start=\"1354\"\u003e\u003cstrong data-end=\"1381\" data-start=\"1354\"\u003eBlood Sugar Regulation:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eStimulates insulin secretion in response to high glucose and suppresses glucagon production, supporting stable blood sugar control.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1632\" data-start=\"1516\"\u003e\n\u003cp data-end=\"1632\" data-start=\"1518\"\u003e\u003cstrong data-end=\"1542\" data-start=\"1518\"\u003eWeight Loss Support:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eReduces appetite and slows gastric emptying, assisting with sustained weight reduction.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1782\" data-start=\"1633\"\u003e\n\u003cp data-end=\"1782\" data-start=\"1635\"\u003e\u003cstrong data-end=\"1665\" data-start=\"1635\"\u003eCardiovascular Protection:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eEvidence suggests a reduction in the risk of major adverse cardiovascular events in patients with type 2 diabetes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"1787\" data-start=\"1784\"\u003e\n\u003ch4 data-end=\"1820\" data-start=\"1789\"\u003e\u003cstrong data-end=\"1818\" data-start=\"1794\"\u003eDosage Instructions:\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp data-end=\"1935\" data-start=\"1821\"\u003eNovo-Lela Semaglutide Auto-Injector Pen is designed for\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"1903\" data-start=\"1877\"\u003esubcutaneous injection\u003c\/strong\u003e, providing a pre-measured dose.\u003c\/p\u003e\n\u003cp data-end=\"1977\" data-start=\"1937\"\u003e\u003cstrong data-end=\"1975\" data-start=\"1937\"\u003eGeneral guidelines are as follows:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"2401\" data-start=\"1978\"\u003e\n\u003cli data-end=\"2175\" data-start=\"1978\"\u003e\n\u003cp data-end=\"2175\" data-start=\"1980\"\u003e\u003cstrong data-end=\"2000\" data-start=\"1980\"\u003eType 2 Diabetes:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eStart with 0.25 mg once weekly for the first four weeks, then increase to 0.5 mg once weekly. The dose may be escalated to 1.0 mg if additional glycaemic control is needed.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2310\" data-start=\"2176\"\u003e\n\u003cp data-end=\"2310\" data-start=\"2178\"\u003e\u003cstrong data-end=\"2200\" data-start=\"2178\"\u003eWeight Management:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eHigher maintenance doses (up to 2.4 mg weekly) may be used based on clinical judgment and patient response.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2401\" data-start=\"2311\"\u003e\n\u003cp data-end=\"2401\" data-start=\"2313\"\u003eAdminister the injection on the same day each week, at any time, with or without food.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"2507\" data-start=\"2403\"\u003eAlways follow your healthcare provider’s instructions to ensure the correct dose and frequency are used.\u003c\/p\u003e\n\u003chr data-end=\"2512\" data-start=\"2509\"\u003e\n\u003ch4 data-end=\"2538\" data-start=\"2514\"\u003e\u003cstrong data-end=\"2536\" data-start=\"2519\"\u003eSide Effects:\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp data-end=\"2628\" data-start=\"2539\"\u003eSemaglutide may cause certain side effects, although many are mild and improve with time:\u003c\/p\u003e\n\u003cul data-end=\"3116\" data-start=\"2630\"\u003e\n\u003cli data-end=\"2740\" data-start=\"2630\"\u003e\n\u003cp data-end=\"2740\" data-start=\"2632\"\u003e\u003cstrong data-end=\"2662\" data-start=\"2632\"\u003eGastrointestinal Symptoms:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eNausea, vomiting, diarrhea, or abdominal discomfort during dose escalation.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2858\" data-start=\"2741\"\u003e\n\u003cp data-end=\"2858\" data-start=\"2743\"\u003e\u003cstrong data-end=\"2760\" data-start=\"2743\"\u003eHypoglycemia:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eUncommon when used alone but can occur if combined with other blood sugar-lowering medications.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2940\" data-start=\"2859\"\u003e\n\u003cp data-end=\"2940\" data-start=\"2861\"\u003e\u003cstrong data-end=\"2890\" data-start=\"2861\"\u003eInjection Site Reactions:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eMild redness, itching, or discomfort may occur.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3020\" data-start=\"2941\"\u003e\n\u003cp data-end=\"3020\" data-start=\"2943\"\u003e\u003cstrong data-end=\"2960\" data-start=\"2943\"\u003ePancreatitis:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eRare cases of pancreatic inflammation have been reported.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3116\" data-start=\"3021\"\u003e\n\u003cp data-end=\"3116\" data-start=\"3023\"\u003e\u003cstrong data-end=\"3047\" data-start=\"3023\"\u003eGallbladder Effects:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eLong-term use may increase the risk of gallbladder-related events.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"3230\" data-start=\"3118\"\u003ePatients should consult their healthcare provider regarding monitoring and management of potential side effects.\u003c\/p\u003e\n\u003chr data-end=\"3235\" data-start=\"3232\"\u003e\n\u003ch4 data-end=\"3258\" data-start=\"3237\"\u003e\u003cstrong data-end=\"3256\" data-start=\"3242\"\u003eHalf-life:\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp data-end=\"3464\" data-start=\"3259\"\u003eSemaglutide has a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"3308\" data-start=\"3277\"\u003ehalf-life of about one week\u003c\/strong\u003e, allowing for\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"3349\" data-start=\"3323\"\u003eonce-weekly injections\u003c\/strong\u003e. This extended activity ensures consistent glucose control and facilitates weight management without daily dosing.\u003c\/p\u003e\n\u003chr data-end=\"3469\" data-start=\"3466\"\u003e\n\u003cp data-end=\"3816\" data-start=\"3471\"\u003e\u003cstrong data-end=\"3485\" data-start=\"3471\"\u003eIn summary\u003c\/strong\u003e, Novo-Lela Semaglutide 4mg Auto-Injector Pen offers the same therapeutic benefits as traditional delivery methods, with the added convenience of a prefilled pen. It is a clinically effective GLP-1 receptor agonist that supports blood sugar control, weight loss, and cardiovascular health as part of a comprehensive treatment plan.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":51003304608042,"sku":null,"price":2250.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0974\/2132\/8682\/files\/Semaglutide-4mg.webp?v=1767190507","url":"https:\/\/myantidote.co.za\/products\/semaglutide-4mg-auto-injector-pen","provider":"My Antidote","version":"1.0","type":"link"}